Wednesday, 19 January, 2022 - 11:47
Corporate advisers upbeat on 2022 deal flow
“It has been a busy year and it continues to be,” is how Simon Reed describes current market conditions in Western Australia.
Hamish Douglass is the co-founder, chair and chief investment officer of Magellan Financial Group, and lead portfolio manager of Magellan’s Global Equity strategies. He is also a director of the Victor Chang Cardiac Research Institute.
Mr Douglass was a member of the Australian Government's Foreign Investment Review Board (FIRB), the Australian Government's Financial Literacy Board, acting president of the Australian Government's Takeovers Panel, and co-head of global banking at Deutsche Bank, Australasia.
Rank | Company | 1 Yr | 5 Yr |
---|---|---|---|
252nd | Fisher & Paykel Healthcare Corporation">Fisher & Paykel Healthcare Corporation | 58.28% | 12.12% |
253rd | Queste Communications">Queste Communications | 58.2% | -4.6% |
254th | Magellan Financial Group">Magellan Financial Group | 57.94% | -20.92% |
255th | XRF Scientific">XRF Scientific | 57.87% | 55.63% |
256th | Aspen Group">Aspen Group | 57.45% | 21.95% |
![]() |
NEW ROLE: Non-Executive Director, Victor Chang Cardiac Research Institute | 10 Aug 2022 |
![]() |
NEWS: Tagged in Corporate advisers upbeat on 2022 deal flow | 19 Jan 2022 |
![]() |
NEW ROLE: Co-Founder, Chief Investment Officer, Chief Executive, Magellan Global Trust | 03 Nov 2020 |
![]() |
NEW ROLE: Co-Founder, Chief Investment Officer since 2015, Executive Chair since 2018, Magellan Financial Group | 03 Nov 2020 |
“It has been a busy year and it continues to be,” is how Simon Reed describes current market conditions in Western Australia.
Access to our data for Hamish Douglass is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Hamish Douglass is linked to 4 organisations which are included in 1 list - Public Companies - non WA.
To see the data you will need to Subscribe.